Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Bazedoxifene and Cholecalciferol Coadministration
NCT03005340Phase 1Unknown
- Sponsor
- Alvogen
- Start
- Dec 2016
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 1, randomised, open-label trial of bazedoxifene and vitamin d in osteoporosis (6 arms), sponsored by Alvogen. Primary endpoints: Area under the plasma concentration versus time curve (AUCt) of Bazedoxifene at 120 hours, Area under the plasma concentration versus time curve (AUCt) of Cholecalciferol at 96 hours and 2 more. Status: unknown.
02
Drugs
bazedoxifenevitamin d
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT03005340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03005340.